Localized juvenile spongiotic gingival hyperplasia
Localized juvenile spongiotic gingival hyperplasia (LJSGH) is a poorly understood entity and is probably a misnomer too. Although this lesion is thought to be predominantly found in young children, a significant number of cases have also been reported in
Nitya Kala, Harikrishnan Prasad
doaj +4 more sources
Untypical Amlodipine-Induced Gingival Hyperplasia [PDF]
Amlodipine is a third generation dihydropyridine calcium channel blocker that is frequently used in therapy of hypertension. Among many side effects, amlodipine has been found associated with gingival overgrowth (GO) which usually occurs within the first
Verica Pavlic +3 more
doaj +5 more sources
Spongiotic Gingival Hyperplasia in a Child with Asperger Syndrome: a Case Report [PDF]
Background: Asperger syndrome is a type of autism spectrum disorder that may affect oral health and dental management. Spongiotic gingival hyperplasia is a rare lesion with unique clinicopathological features and unknown pathogenesis that has not been ...
Aikaterini Aktypi-Bampouranou +4 more
doaj +2 more sources
Calcium channel blockers- Induced iatrogenic gingival hyperplasia: Case series
Hypertension rightfully termed as “Silent killer” is associated with increase in morbidity and mortality when left untreated. Calcium channel blockers are the most commonly prescribed first-line anti-hypertensive drugs in India.
G Agnes Golda Priyadarshini +4 more
doaj +2 more sources
Amlodipine-Induced Gingival Hyperplasia in a Young Male with Stage 5 Chronic Kidney Disease [PDF]
Gingival hyperplasia is a rare finding in clinical practice. Nevertheless, when it occurs, it is a finding of great value as it can lead to definite clinical diagnosis.
Kevin John +3 more
doaj +2 more sources
Oral Juvenile Xanthogranuloma: a case report of gingival hyperplasia and osteolysis in male adult patient [PDF]
Background Juvenile Xanthogranuloma (JXG) is a non-hereditary, self-limiting disease which is usually presented in infancy or early childhood and in males over females.
Long Chen, Lin Feng, Lingling E
doaj +2 more sources
Levetiracetam-induced gingival hyperplasia.
Levetiracetam is a new generation antiseizure medication which binds to synaptic vesicle protein SV2A and inhibits the release of neurotransmitters. Gingival hyperplasia is a common side effect of conventional antiseizure medications like phenytoin, but very rare with the newer ones.
James J, Jose J, Gafoor VA.
europepmc +3 more sources
Antihypertensive treatment with telmisartan in a cat with amlodipine-induced gingival hyperplasia [PDF]
Case summary Systemic arterial hypertension is commonly reported in middle-aged-to-older cats. Amlodipine is recommended as the initial antihypertensive drug in cats.
Lien Desmet, Jeroen van der Meer
doaj +2 more sources
Cellular immunity indexes after therapeutic use of immunoactive and anti-inflammatory agents in patients with orthodontically induced gingival hyperplasia [PDF]
Orthodontic treatment with fixed appliances that is mediated by the power forces of the apparatus might lead to changes in the blood circulation, predispose to a number of complications such as tooth movement and contributes to the morphological bone ...
Andrii Babenko +4 more
doaj +3 more sources

